No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Kontafarma China Holdings Ltd. directs its business efforts through two principal segments: Pharmaceutical and Fitness. Its Pharmaceutical arm is responsible for the manufacturing and marketing of prescription medications and associated laboratory goods. Meanwhile, the Fitness division oversees the management of health clubs, delivers advisory services for physical well-being and health-related pursuits, and runs a franchise model to generate royalty revenue. Established on March 21, 2011, the company maintains its corporate headquarters in Hong Kong.
www.kontafarma.com.hkNo one on the platform currently holds 1312.HK.
No tracked institution reports a position in 1312.HK as of their last filing.
No one on the platform has traded 1312.HK yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 1312.HKKontafarma China Holdings Ltd | $0.03 | +10.00% | $184M | — |
| 0094.HKGreenheart Group Limited | $0.05 | -2.04% | $134M | — |
| 0637.HKLee Kee Holdings Limited | $0.18 | -0.56% | $146M | — |
| 0827.HKKo Yo Chemical (Group) Limited | $0.04 | -6.52% | $302M | — |
| 0954.HKChangmao Biochemical Engineering Company Limited | $0.22 | +0.46% | $116M | — |
| 1932.HKCPM Group Limited | $0.13 | +1.56% | $130M | — |
| 1950.HKDiwang Industrial Holdings Limited | $0.11 | +0.00% | $80M | — |
Source: Financial Modeling Prep · peers by sector/industry